Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.
Download PDF

Association between serum zinc and copper concentrations and copper/zinc ratio with the prevalence of knee chondrocalcinosis: a cross-sectional study

BMC Musculoskeletal Disorders volume 21, Article number: 97 (2020) Cite this article

Abstract

Background

Patients with chondrocalcinosis may suffer from a series of symptoms resembling acute gouty arthritis or septic arthritis, but the aetiology and pathogenesis of chondrocalcinosis have not been fully elucidated yet. This study was aimed to assess serum zinc and copper concentrations, as well as the ratio of serum copper to zinc concentrations (Cu/Zn ratio), in relation to the prevalence of knee chondrocalcinosis.

Methods

Data included in this analysis were retrieved from a large population-based cross-sectional study. A bilateral knee anteroposterior radiograph was obtained from each subject. Radiographic knee chondrocalcinosis was diagnosed if definite linear cartilage calcification was detected. Serum zinc and copper concentrations were measured using the spectrophotometric flow injection methods by Roche modular P800. The relations of serum zinc and copper concentrations and Cu/Zn ratio to the prevalence of knee chondrocalcinosis were examined using generalized estimating equations, respectively.

Results

The prevalence of knee chondrocalcinosis was 1.2% in the sample of this study (n = 12,362). In comparison with the lowest tertile, the odds ratios (ORs) of knee chondrocalcinosis adjusted by age, sex and body mass index were 0.74 (95% CI 0.50–1.09) in the second and 0.56 (95% CI 0.36–0.86) in the third tertiles of serum zinc concentrations (P for trend = 0.009), were 1.26 (95% CI 0.77–2.05) in the second and 2.01 (95% CI 1.25–3.24) in the third tertile of serum copper concentrations (P for trend = 0.003), and were 1.02 (95% CI 0.61–1.69) in the second and 2.23 (95% CI 1.38–3.59) in the third tertile of Cu/Zn ratio (P for trend < 0.001) respectively. These findings were not materially altered by adjustment for potential confounders.

Conclusions

The present study observed that higher serum zinc concentrations, lower serum copper concentrations or lower Cu/Zn ratio are associated with a lower prevalence of knee chondrocalcinosis in a dose-response relationship manner.

Peer Review reports

Background

Chondrocalcinosis is a disease characterized by the formation of calcium pyrophosphate and basic calcium phosphate crystals in the pericellular matrix of cartilage, and by the calcification of articular fibrocartilage and hyaline cartilage [1,2,3]. Patients with chondrocalcinosis may suffer from fever, joint pain and a series of other clinical symptoms that are similar to acute gouty arthritis or septic arthritis and chronic symptoms resembling osteoarthritis, which all contributes to a compromised quality of life and a worsened comorbidity [4,5,6,7,8]. As for asymptomatic patients, though no clinical symptoms manifested, the crystals deposited on the cartilage surface may cause or accelerate joint damage by activating inflammatory response, altering the mechanical stress distribution on the cartilage surface and acting as wear particles, which was postulated as a condition representing a presymptomatic phase of clinical arthritis [9, 10]. However, the aetiology and pathogenesis of chondrocalcinosis have not been fully elucidated.

As important trace elements in the human body, zinc and copper are both involved in many homeostatic mechanisms, including immunity and inflammation [11,12,13]. While zinc was believed to be an anti-inflammatory factor, copper was suggested to be a proinflammatory agent [13, 14]. Previous studies have reported that many common diseases, such as cardiovascular disease, cancer, type 2 diabetes, Alzheimer’s disease, vitiligo and multiple sclerosis were associated with lower zinc concentrations and higher copper concentrations, of which the underlying mechanisms were suspected to be attributed to immune function, inflammatory response and oxidative stress [15,16,17,18,19,20]. In addition, not only is the individual concentrations of serum copper and zinc of concern, but the balance between these two elements appears to be important. Previous studies suggested that calculating the ratio of serum copper to zinc concentrations, hereafter referred to as Cu/Zn ratio, provided valuable information in regard to oxidative stress and inflammatory responses [21]. Due to the essential role of inflammatory response in the pathogenesis of chondrocalcinosis [22, 23], it was postulated that there might be a potential link between the serum zinc and copper concentrations, as well as Cu/Zn ratio, and the prevalence of chondrocalcinosis. However, to our best knowledge, no study has been performed to investigate these correlations yet.

To fill in the knowledge gap, data were collected from a large population-based cross-sectional study and used to examine the relationship between serum zinc and copper concentrations and Cu/Zn ratio with the prevalence of knee chondrocalcinosis so as to determine the shape of the corresponding dose-response relationship if it exists.

Methods

Study population

The subjects of this cross-sectional study were individuals from the general population who had undergone routine health examinations at Xiangya Hospital, Central South University in Changsha, Hunan, China, between October 2013 and December 2015. Identical study designs have already been reported in some previous publications [24,25,26]. Briefly speaking, the routine health checkups include anthropometric measurements (such as height and body mass), basic clinical tests (such as blood pressure and heart rate), biochemistry (such as blood tests, liver function, kidney function and trace element tests) and imaging tests (such as chest radiography and weight-bearing bilateral anterior-posterior knee radiography). The subjects qualified for this study were individuals satisfying the following inclusion criteria: (1) age ≥ 40 years; (2) completed the serum zinc and serum copper tests; (3) provided bilateral weight-bearing anteroposterior and bilateral axial knee X-ray films. Prior to the start of the study, all the involved interviewers, clinical inspectors, and X-ray technicians had been properly trained by the leading researchers.

During the study period, 31,542 participants underwent routine health checkups at the aforementioned study center and 12,420 of them met all the inclusion criteria. Then, 58 participants were eliminated according to the exclusion criteria: (1) the weight-bearing anteroposterior knee radiograph was in unsatisfactory quality (n = 53); and (2) the Kellgren-Lawrence (KL) [27] grades of both knees were 4 (n = 5). Eventually, 12,362 participants were included in the final analysis.

Blood biochemical analysis

The venous blood sample was collected from each subject upon an overnight fast of 12 h with a serum separation tube (containing silica clot activators and gel separator) and was immediately centrifuged at 4 °C for 10 min at 3000 relative centrifugal force. The serum zinc and serum copper concentrations were detected by the spectrophotometric flow injection methods, “2-(5-Bromo-2-pyridylazo)-5-[N-propyl-N-(3-sulfopropyl) amino] phenol”, i.e., 5-Br-PAPS, and the “4-(3,5-dibromo-2-pyridylazo)-N-ethyl-N-(3-sulfopropyl) aniline”, i.e., 3,5-diBr-PAESA, respectively, using Roche modular P800 [28,29,30].

The inter-assay coefficients of variation were 4.44% (10.1 μmol/L) and 2.50% (18.5 μmol/L) and the intra-assay coefficients of variation were 2.86% (18.74 μmol/L) and 3.42% (9.49 μmol/L) for serum zinc. Likewise, the inter-assay coefficients of variation were 6.15% (9.8 μmol/L) and 4.33% (16.5 μmol/L), and the intra-assay coefficients of variation were 5.17% (16.72 μmol/L) and 5.37% (8.86 μmol/L) for serum copper. The measuring methods and data reliability of potential confounders (e.g., serum iron, calcium, magnesium and phosphorus) are shown in Additional file 1.

Assessment of radiographic knee chondrocalcinosis

Two orthopaedic surgeons were engaged to evaluate all the X-ray films while remaining blinded to the clinical and biochemical findings of corresponding subjects. Radiographic chondrocalcinosis was defined by evidence of knee joint linear cartilage calcification [31]. Specifically, prior to the assessment, the two orthopaedic surgeons were requested to review 200 X-rays films from the Osteoarthritis Initiative (OAI) for calibration purpose until they had agreed with each other on all these readings to a high level (the cutoff of simple kappa for the inter-rater reliability was 0.70). Then, the formal reading process started by reading each batch of knee X-rays in a mixed manner (100 X-rays in one batch: 10 previously-read X-rays and 90 unread X-rays that were randomly selected). The unread radiographs were utilized to test the inter-rater reliability, while the previously-read radiographs were utilized to test the intra-rater reliability. Both surgeons were requested to evaluate all the X-rays, and the inconsistencies, if any, were resolved through discussion. The Kappa value of the X-ray reliability reading was 0.72 (95% CI 0.67–0.77) for the inter-evaluator and 0.76 (95% CI 0.67–0.85) for the assessor’s internal reliability [24].

Statistical analysis

The continuous data were expressed in the form of mean ± standard deviation, and the categorical data were expressed in the form of proportion (percentage). According to the tertile distribution in the study population, the serum zinc and copper concentrations were classified into three categories (i.e., ≤ 12.1, 12.2–14.2, and ≥ 14.3 mmol/L for zinc; and ≤ 14.7, 14.8–17.5, and ≥ 17.6 mmol/L for copper). Cu/Zn ratio was also calculated, and then classified into three categories according to its tertile distribution (i.e., ≤ 1.07, 1.08–1.38, and ≥ 1.39). The generalized estimating equation [32] was used to investigate the association of each of the serum zinc, copper and Cu/Zn ratio categories with chondrocalcinosis, under adjustment of potential confounders (knee-specificity analysis). The binary distribution and the logit linkage of the PROC GENMOD program in SAS were used to calculate the odds ratio (OR) and the related 95% confidence interval (95% CI) of chondrocalcinosis among various serum zinc and copper and Cu/Zn ratio categories, with the lowest tertile of serum zinc or copper or Cu/Zn ratio being taken as the reference. Specifically, the confounders of age (40–49 years old, 50–59 years old, 60–69 years old, ≥ 70 years old), body mass index (BMI) (< 28, ≥ 28 kg/m2) and sex (male, female) were adjusted first. Then, each of the following covariates: serum iron (tertiles), serum calcium (tertiles), serum magnesium (tertiles), serum zinc (tertiles), serum copper (tertiles) and serum phosphorus (tertiles) was added into the regression model.

Subsequently, the dose-response relationships between the serum zinc and copper concentrations and Cu/Zn ratio with the prevalence of knee chondrocalcinosis were plotted by generalized additive models with spline regression [33].

Results

A total of 12,362 subjects (7017 men and 5345 women) aged ≥40 years (average 52.1 ± 7.9 years) were included in the analysis. The prevalence of knee chondrocalcinosis in the entire sample was 1.2% (Table 1).

Table 1 Basic characteristics among 12,362 participants according to knee chondrocalcinosis status
Full size table

Figure 1 shows the linear association between the serum zinc and predicted prevalence of chondrocalcinosis. Compared with the lowest tertile of serum zinc, the prevalence of knee chondrocalcinosis decreased by 0.5% in the middle and 0.9% in the highest. As shown in model 1, the ORs (95% CIs) for knee chondrocalcinosis, with adjustment for age, sex and BMI, were 0.74 (95% CI 0.50–1.09) and 0.56 (95% CI 0.36–0.86) from the second to the highest tertile of serum zinc, respectively, compared with the lowest tertile (P for trend = 0.009). With further adjustment for serum iron (model 2), calcium (model 3), magnesium (model 4), copper (model 5) and phosphorus (model 6) on the basis of model 1, the results were not substantially altered (Table 2).

Fig. 1
figure1

Association between serum zinc and predictive prevalence of chondrocalcinosis

Full size image
Table 2 Association between serum zinc and knee chondrocalcinosis (n = 12,362)
Full size table

The dose-response relationship between the serum copper and predicted prevalence of chondrocalcinosis is shown in Fig. 2. The prevalence of knee chondrocalcinosis was 0.8% in the lowest tertile of serum copper and increased by 0.3% in the middle and 1.1% in the highest. The age, sex and BMI adjusted ORs (95% CIs) for knee chondrocalcinosis were 1.26 (95% CI 0.77–2.05) and 2.01 (95% CI 1.25–3.24) from the second to the highest tertile of serum copper, respectively, compared with the lowest tertile (P for trend = 0.003) (model 1). The results were not materially changed after further adjustment for potential confounders on the basis of model 1 (Table 3).

Fig. 2
figure2

Association between serum copper and predictive prevalence of chondrocalcinosis

Full size image
Table 3 Association between serum copper and knee chondrocalcinosis (n = 12,362)
Full size table

Figure 3 illustrates the dose-response relationship between Cu/Zn ratio and predicted prevalence of chondrocalcinosis. A positive association between Cu/Zn ratio and the prevalence of chondrocalcinosis is illustrated in Table 4. The results did not change substantially after adjustment for potential confounders (i.e., age, sex, BMI, serum iron, serum calcium, serum magnesium and serum phosphorus).

Fig. 3
figure3

Association between Cu/Zn ratio and predictive prevalence of chondrocalcinosis. Cu/Zn ratio, the ratio of serum copper to zinc concentrations

Full size image
Table 4 Association between Cu/Zn ratio and knee chondrocalcinosis (n = 12,362)
Full size table

Discussion

To our best knowledge, this is the first study revealing positive associations between the serum copper, Cu/Zn ratio and the prevalence of chondrocalcinosis, as well as an inverse association between the serum zinc and the prevalence of chondrocalcinosis in contrast. Our findings are independent of some major confounders, such as age, sex, BMI, iron, calcium, magnesium, copper, zinc, and phosphorus, suggesting that the observed associations are robust.

While the biological mechanisms of linking the concentrations of serum zinc and copper to the risk of knee chondrocalcinosis are not fully understood, the inflammatory response may partly explain these findings. Zinc deficiency can lead to a proinflammatory status [13]. Previous studies have shown that a lower level of zinc concentration could reduce the natural killer cell immune activity, alter the inflammatory cytokine production, and impair the function of superoxide dismutase which would in turn alleviate the inflammatory response by converting O2− free radicals into O2 and H2O2 [34,35,36,37,38]. On the contrary, a higher level of copper concentration could accelerate the catalytic action of H2O2 into hydroxyl radicals, which would then strengthen the reactive oxygen species-dependent killing in macrophages and thereby aggravate the inflammatory response [39].

The deposition of calcium pyrophosphate crystals on articular fibrocartilage or hyaline cartilage is one of the most typical features of chondrocalcinosis, and it can mediate tissue damage through the inflammatory mechanism [1, 2]. Extracellular trap release can be increased in human neutrophils activated by microcrystals, and the NALP3 inflammasome is induced once the calcium pyrophosphate crystals are deposited [9, 22]. In addition, calcium pyrophosphate crystals can directly catabolize chondrocytes and synoviocytes, resulting in the production of destructive matrix metalloproteinases and prostaglandins, which are both of great importance in the process of inflammatory response [23, 40]. Thus, the inflammatory response may explain, at least in part, the significant associations between the serum zinc and copper concentrations and the prevalence of chondrocalcinosis.

Cu/Zn ratio reflects the balance between copper and zinc in the human body. Rather than a simple nutritional indicator, previous studies showed that it could also be a potential biomarker of inflammatory response and oxidative stress [21, 41]. Moreover, it has been reported to be positively correlated with disability and mortality in elderly subjects aged 70 years and above [21]. The present study showed that lower Cu/Zn ratio is associated with a lower prevalence of knee chondrocalcinosis, which also assessed the robustness of our findings of the associations between serum zinc and copper concentrations and the prevalence of chondrocalcinosis, to some extent.

Several advantages of this study are noteworthy. First of all, a large sample size (n = 12,362) of this first study investigating the association between serum zinc and copper concentrations and Cu/Zn ratio and knee chondrocalcinosis guaranteed that our findings are likely to be of a low occasionality. Second, the serum zinc, copper concentrations and Cu/Zn ratio are respectively correlated with the prevalence of chondrocalcinosis in a dose-response manner. This observation has important implications for both zinc and copper as trace elements and for the disease of chondrocalcinosis itself, suggesting that there may be correlations between these two elements and the pathogenesis of chondrocalcinosis.

However, this study is also involved with several caveats. First, we cannot draw a causal relationship between the serum zinc and copper concentrations and Cu/Zn ratio and the prevalence of chondrocalcinosis due to the cross-sectional design. Nevertheless, as no previous research has investigated the associations between these two elements and chondrocalcinosis, the value of this study should not be diminished. Second, other views of the knee (such as lateral or skyline) were not used to in our study ascertain radiographic chondrocalcinosis; thus, the prevalence of radiographic chondrocalcinosis might be underestimated. Third, the synovial fluid (taken from the joint) test should be more sensitive and specific than radiographs for detecting crystals, and some of the articular calcium pyrophosphate depositions may be too small to be detected on radiographs; thus, our estimation of the prevalence of knee chondrocalcinosis is likely to be underestimated.

Conclusions

The present study observed that higher serum zinc concentrations, lower serum copper concentrations or lower Cu/Zn ratio are associated with a lower prevalence of knee chondrocalcinosis in a dose-response relationship manner.

Availability of data and materials

Data can be requested from the corresponding author.

Abbreviations

3,5-diBr-PAESA:

4-(3,5-dibromo-2-pyridylazo)-N-ethyl-N-(3-sulfopropyl) aniline

5-Br-PAPS:

2-(5-Bromo-2-pyridylazo)-5-[N-propyl-N-(3-sulfopropyl) amino] phenol

BMI:

Body mass index

CI:

Confidence interval

Cu/Zn ratio:

The ratio of serum copper to zinc concentrations.

KL:

Kellgren-Lawrence

OAI:

Osteoarthritis Initiative

OR:

Odds ratio

References

  1. 1.

    Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374:2575–84.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Abhishek A, Doherty M. Pathophysiology of articular chondrocalcinosis—role of ANKH. Nat Rev Rheumatol. 2011;7:96–104.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Abhishek A. Calcium pyrophosphate deposition disease: a review of epidemiologic findings. Curr Opin Rheumatol. 2016;28(2):133–9.

    CAS  PubMed  Article  Google Scholar 

  4. 4.

    Bong D, Bennett R. Pseudogout mimicking systemic disease. JAMA. 1981;246:1438–40.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Kohn NN, Hughes RE, McCarty DJ, Faires JS. The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals. Ann Intern Med. 1962;56:738–45.

    CAS  PubMed  Article  Google Scholar 

  6. 6.

    Doll NJ, Jackson FN. Acute pseudogout simulating septic arthritis. JAMA. 1979;242:1768.

    CAS  PubMed  Article  Google Scholar 

  7. 7.

    Musacchio E, Ramonda R, Perissinotto E, Sartori L, Hirsch R, Punzi L, Zambon S, Corti MC, Baggio G, Manzato E, Doria A, Crepaldi G. The impact of knee and hip chondrocalcinosis on disability in older people: the ProVA study from northeastern Italy. Ann Rheum Dis. 2011;70(11):1937–43.

    PubMed  Article  Google Scholar 

  8. 8.

    Abhishek A, Neogi T, Choi H, Doherty M, Rosenthal AK, Terkeltaub R. Review: unmet needs and the path forward in joint disease associated with calcium pyrophosphate crystal deposition. Arthritis Rheumatol. 2018;70(8):1182–91.

    PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–41.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    Muehleman C, Li J, Aigner T, Rappoport L, Mattson E, Hirschmugl C, Masuda K, Rosenthal AK. Association between crystals and cartilage degeneration in the ankle. J Rheumatol. 2008;35:1108–17.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007;98:S29–35.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Mocchegiani E, Costarelli L, Giacconi R, Piacenza F, Basso A, Malavolta M. Micronutrient (Zn, cu, Fe)-gene interactions in ageing and inflammatory age-related diseases: implications for treatments. Ageing Res Rev. 2012;11:297–319.

    CAS  PubMed  Article  Google Scholar 

  13. 13.

    Mariani E, Cattini L, Neri S, Malavolta M, Mocchegiani E, Ravaglia G, Facchini A. Simultaneous evaluation of circulating chemokine and cytokine profiles in elderly subjects by multiplex technology: relationship with zinc status. Biogerontology. 2006;7:449–59.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Kim CH, Park JY, Kim JY, Choi CS, Kim YI, Chung YE, Lee MS, Hong SK, Lee KU. Elevated serum ceruloplasmin levels in subjects with metabolic syndrome: a population-based study. Metabolism. 2002;51(7):838–42.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Leone N, Courbon D, Ducimetiere P, Zureik M. Zinc, copper, and magnesium and risks for all-cause, Cancer, and cardiovascular mortality. Epidemiology. 2006;17:308–14.

    PubMed  Article  PubMed Central  Google Scholar 

  16. 16.

    Mocchegiani E, Giacconi R, Malavolta M. Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes. Trends Mol Med. 2008;14:419–28.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  17. 17.

    Aguilar MV, Saavedra P, Arrieta FJ, Mateos CJ, González MJ, Meseguer I, Martínez-Para MC. Plasma mineral content in type-2 diabetic patients and their association with the metabolic syndrome. Ann Nutr Metab. 2007;51:402–6.

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Barnham KJ, Bush AI. Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol. 2008;12:222–8.

    CAS  PubMed  Article  Google Scholar 

  19. 19.

    Socha K, Karpinska E, Kochanowicz J, Soroczynska J, Jakoniuk M, Wilkiel M, Mariak ZD, Borawska MH. Dietary habits; concentration of copper, zinc, and Cu-to-Zn ratio in serum and ability status of patients with relapsing-remitting multiple sclerosis. Nutrition. 2017;39–40:76–81.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  20. 20.

    Wacewicz M, Socha K, Soroczynska J, Niczyporuk M, Aleksiejczuk P, Ostrowska J, Borawska MH. Selenium, zinc, copper, cu/Zn ratio and total antioxidant status in the serum of vitiligo patients treated by narrow-band ultraviolet-B phototherapy. J Dermatolog Treat. 2018;29(2):190–5.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Malavolta M, Giacconi R, Piacenza F, Santarelli L, Cipriano C, Costarelli L, Tesei S, Pierpaoli S, Basso A, Galeazzi R, Lattanzio F, Mocchegiani E. Plasma copper/zinc ratio: an inflammatory/nutritional biomarker as predictor of all-cause mortality in elderly population. Biogerontology. 2010;11(3):309–19.

    CAS  PubMed  Article  Google Scholar 

  22. 22.

    Pang L, Hayes CP, Buac K, Yoo D-G, Rada B. Pseudogout-associated inflammatory calcium pyrophosphate dihydrate microcrystals induce formation of neutrophil extracellular traps. J Immunol. 2013;190:6488–500.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol. 2005;174:5016–23.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Zeng C, Wei J, Terkeltaub R, Yang T, Choi HK, Wang Y-L, Xie D-X, Hunter DJ, Zhang Y, Li H, Cui Y, Li L-J, Lei G-H. Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis. Arthritis Res Ther. 2017;19:236.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  25. 25.

    Zeng C, Wei J, Li H, Yang T, Zhang F-J, Pan D, Xiao Y-B, Yang T-B, Lei G-H. Relationship between serum magnesium concentration and radiographic knee osteoarthritis. J Rheumatol. 2015;42:1231–6.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Wang Y, Wei J, Zeng C, Yang T, Li H, Cui Y, Xie D, Xu B, Liu Z, Li J, Jiang S, Lei G. Association between serum magnesium concentration and metabolic syndrome, diabetes, hypertension and hyperuricaemia in knee osteoarthritis: a cross-sectional study in Hunan Province, China. BMJ open. 2018;8:e019159.

    PubMed  PubMed Central  Article  Google Scholar 

  27. 27.

    Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16:494–502.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  28. 28.

    Makino T, Saito M, Horiguchi D, Kina K. A highly sensitive colorimetric determination of serum zinc using water-soluble pyridylazo dye. Clin Chim Acta. 1982;120(1):127–35.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Homsher R, Zak B. Spectrophotometric investigation of sensitive complexing agents for the determination of zinc in serum. Clin Chem. 1985;31(8):1310–3.

    CAS  PubMed  Article  Google Scholar 

  30. 30.

    Kimura S, Iyama S, Yamaguchi Y, Hayashi S, Fushimi R, Amino N. New enzymatic assay with urea amidolyase for determining potassium in serum. Ann Clin Biochem. 1997;34(Pt 4):384–8.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Abhishek A, Doherty S, Maciewicz R, Muir K, Zhang W, Doherty M. Chondrocalcinosis is common in the absence of knee involvement. Arthritis Res Ther. 2012;14:R205.

    PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Zhang Y, Glynn RJ, Felson DT. Musculoskeletal disease research: should we analyze the joint or the person? J Rheumatol. 1996;23:1130–4.

    CAS  PubMed  Google Scholar 

  33. 33.

    Hastie T, Tibshirani R. Generalized additive models for medical research. Stat Methods Med Res. 1995;4(3):187–96.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Muzzioli M, Stecconi R, Moresi R, Provinciali M. Zinc improves the development of human CD34+ cell progenitors towards NK cells and increases the expression of GATA-3 transcription factor in young and old ages. Biogerontology. 2009;10:593–604.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Mocchegiani E, Muzzioli M, Giacconi R, Cipriano C, Gasparini N, Franceschi C, Gaetti R, Cavalieri E, Suzuki H. Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech Ageing Dev. 2003;124:459–68.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Mariani E, Mangialasche F, Feliziani FT, Cecchetti R, Malavolta M, Bastiani P, Baglioni M, Dedoussis G, Fulop T, Herbein G, Jajte J, Monti D, Rink L, Mocchegiani E, Mecocci P. Effects of zinc supplementation on antioxidant enzyme activities in healthy old subjects. Exp Gerontol. 2008;43:445–51.

    CAS  PubMed  Article  Google Scholar 

  37. 37.

    Yasui K, Kobayashi N, Yamazaki T, Agematsu K, Matsuzaki S, Ito S, Nakata S, Baba A, Koike K. Superoxide dismutase (SOD) as a potential inhibitory mediator of inflammation via neutrophil apoptosis. Free Radic Res. 2005;39:755–62.

    CAS  PubMed  Article  Google Scholar 

  38. 38.

    Yasui K, Baba A. Therapeutic potential of superoxide dismutase (SOD) for resolution of inflammation. Inflamm Res. 2006;55:359–63.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  39. 39.

    White C, Lee J, Kambe T, Fritsche K, Petris MJ. A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity. J Biol Chem. 2009;284:33949–56.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  40. 40.

    Reuben PM, Wenger L, Cruz M, Cheung HS. Induction of matrix metalloproteinase-8 in human fibroblasts by basic calcium phosphate and calcium pyrophosphate dihydrate crystals: effect of phosphocitrate. Connect Tissue Res. 2001;42:1–12.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Mezzetti A, Pierdomenico SD, Costantini F, Romano F, De Cesare D, Cuccurullo F, Imbastaro T, Riario-Sforza G, Di Giacomo F, Zuliani G, Fellin R. Copper/zinc ratio and systemic oxidant load: effect of aging and aging-related degenerative diseases. Free Radic Biol Med. 1998;25(6):676–81.

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgements

The authors appreciate the support of Orthopedics Research Institute of Xiangya Hospital.

Funding

This work was supported by the Innovation Foundation of the Central South University for Postgraduate (2018zzts045), the National Natural Science Foundation of China (81772413), the Scientific Research Project of Science and Technology Office of Hunan Province (2017TP1005), the Key Research and Development Program of Hunan Province (2018SK2070, 2018SK2071), the Xiangya Clinical Big Data System Construction Project of Central South University (45), the Clinical Scientific Research Foundation of Xiangya Hospital, Central South University (2015 L03).

Author information

Author notes

  1. Hongyi He and Yilun Wang contributed equally to this work.

Affiliations

  1. Department of Orthopaedics, Xiangya Hospital, Central South University, #87 Xiangya Road, Changsha, 410008, Hunan Province, China
    • Xiang Ding
    • , Guanghua Lei
    • , Hui Li
    •  & Dongxing Xie
  2. Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China
    • Zidan Yang
  3. Health Management Center, Xiangya Hospital, Central South University, Changsha, Hunan, China
    • Tuo Yang
  4. Hunan Engineering Research Center of Osteoarthritis, Changsha, Hunan, China
    • Guanghua Lei
  5. Hunan Key Laboratory of Joint Degeneration and Injury, Changsha, Hunan, China
    • Guanghua Lei
  6. National Clinical Research Center of Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China
    • Guanghua Lei
Authors
  1. Hongyi He
    View author publications
    You can also search for this author in
  2. Yilun Wang
    View author publications
    You can also search for this author in
  3. Zidan Yang
    View author publications
    You can also search for this author in
  4. Xiang Ding
    View author publications
    You can also search for this author in
  5. Tuo Yang
    View author publications
    You can also search for this author in
  6. Guanghua Lei
    View author publications
    You can also search for this author in
  7. Hui Li
    View author publications
    You can also search for this author in
  8. Dongxing Xie
    View author publications
    You can also search for this author in

Contributions

DXX had full access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. HYH and YLW conceived the study. HYH and YLW were responsible for conception and design of the study and drafted the manuscript. ZDY, XD, TY and GHL contributed to data collection. TY and YLW contributed to assessment of radiographs. ZDY contributed to preparation and data analysis. HL and GHL contributed to revision of the manuscript. All the authors contributed to the interpretation of the data and critically reviewed the manuscript for publication. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Dongxing Xie.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Xiangya Hospital, Central South University (reference numbers: 201312459), and written informed consent was obtained from all study participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

He, H., Wang, Y., Yang, Z. et al. Association between serum zinc and copper concentrations and copper/zinc ratio with the prevalence of knee chondrocalcinosis: a cross-sectional study. BMC Musculoskelet Disord 21, 97 (2020). https://doi.org/10.1186/s12891-020-3121-z

Download citation

Keywords

  • Zinc
  • Copper
  • Chondrocalcinosis

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us